Physician profile
Sany Kumar
NPI 1750877551
$1,570.56
in general payments reported to CMS, 2019-2025
18 companies · $162 in 2025
The $162 reported for 2025 was less than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $439 · 2020: $259 · 2021: $354 · 2022: $74.56 · 2023: $206 · 2024: $77.66 · 2025: $162.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $445.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $444.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $625.69 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $136.67 | 2019 | |
| Glaxosmithkline, LLC. | $106.79 | 2023 | Nucala, Arexvy, Trelegy Ellipta |
| Mallinckrodt Hospital Products INC. | $95.60 | 2025 | Acthar |
| Abbvie INC. | $94.39 | 2021-2022 | |
| United Therapeutics Corporation | $84.86 | 2023-2025 | Tyvaso, Tyvaso |
| Merck Sharp & Dohme LLC | $72.17 | 2020-2021 | |
| Astrazeneca Pharmaceuticals LP | $50.44 | 2024-2025 | Fasenra, Breztri |
| Ironwood Pharmaceuticals, INC | $50.42 | 2020-2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $46.03 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $40.12 | 2023-2024 | Dupixent |
| Boehringer Ingelheim Pharmaceuticals, INC. | $31.16 | 2020-2021 | |
| Baxter Healthcare | $31.08 | 2023 | Hillrom - Life 2000 Ventilation System |
| Alexion Pharmaceuticals, INC. | $28.33 | 2021 | |
| Pfizer INC. | $25.60 | 2020-2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $20.55 | 2023 | |
| Resmed Corp | $15.51 | 2025 | |
| Tetraphase Pharmaceuticals, INC. | $15.15 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sany Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.